AprilBio to issue convertible preferred shares

Financial Impact

NEUTRAL

Key Numbers

• • Initial conversion price: 40,908 KRW per share
• • Minimum preferred dividend rate: 1% of par value annually
• • Lock-up period for new shares: 1 year from electronic registration date

AI Analysis Summary

AprilBio Co.,Ltd. has decided on a paid-in capital increase through the issuance of convertible preferred shares. The initial conversion price is set at 40,908 KRW per share. These new shares will have a minimum annual preferred dividend rate of 1% of their par value and will be cumulative and participating. New shareholders will be subject to a 1-year lock-up period from the electronic registration date, during which conversion rights cannot be exercised. The conversion price is subject to adjustment based on market conditions, including a downward adjustment if the company issues new shares or equity-linked securities at a lower price. The purpose of the capital increase and the specific number of shares or total funding amount are not disclosed in the provided text, making a full assessment of dilution impact difficult. The capital increase is expected to be neutral in the short term, pending further details on the scale and use of funds.